Background: Few randomized trials have evaluated the effect of reducing red meat intake on clinically important outcomes.
Purpose: To summarize the effect of lower versus higher red meat intake on the incidence of cardiometabolic and cancer outcomes in adults.
Data sources: EMBASE, CENTRAL, CINAHL, Web of Science, and ProQuest from inception to July 2018 and MEDLINE from inception to April 2019, without language restrictions.
Study selection: Randomized trials (published in any language) comparing diets lower in red meat with diets higher in red meat that differed by a gradient of at least 1 serving per week for 6 months or more.
Data extraction: Teams of 2 reviewers independently extracted data and assessed the risk of bias and the certainty of the evidence.
Data synthesis: Of 12 eligible trials, a single trial enrolling 48 835 women provided the most credible, though still low-certainty, evidence that diets lower in red meat may have little or no effect on all-cause mortality (hazard ratio [HR], 0.99 [95% CI, 0.95 to 1.03], cardiovascular mortality (HR, 0.98 [CI, 0.91 to 1.06]), and cardiovascular disease (HR, 0.99 [CI, 0.94 to 1.05]). That trial also provided low- to very-low-certainty evidence that diets lower in red meat may have little or no effect on total cancer mortality (HR, 0.95 [CI, 0.89 to 1.01]) and the incidence of cancer, including colorectal cancer (HR, 1.04 [CI, 0.90 to 1.20]) and breast cancer (HR, 0.97 [0.90 to 1.04]).
Limitations: There were few trials, most addressing only surrogate outcomes, with heterogeneous comparators and small gradients in red meat consumption between lower versus higher intake groups.
Conclusion: Low- to very-low-certainty evidence suggests that diets restricted in red meat may have little or no effect on major cardiometabolic outcomes and cancer mortality and incidence.
Primary funding source: None (PROSPERO: CRD42017074074).
Red and Processed Meat Consumption and Risk for All-Cause Mortality and Cardiometabolic Outcomes: A Systematic Review and Meta-analysis of Cohort Studies.Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-0655. Online ahead of print. Ann Intern Med. 2019. PMID: 31569213
Patterns of Red and Processed Meat Consumption and Risk for Cardiometabolic and Cancer Outcomes: A Systematic Review and Meta-analysis of Cohort Studies.Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1583. Online ahead of print. Ann Intern Med. 2019. PMID: 31569217
Reduction of Red and Processed Meat Intake and Cancer Mortality and Incidence: A Systematic Review and Meta-analysis of Cohort Studies.Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-0699. Online ahead of print. Ann Intern Med. 2019. PMID: 31569214
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2. Cochrane Database Syst Rev. 2018. PMID: 30141832 Free PMC article. Review.
Effects on Health Outcomes of a Mediterranean Diet With No Restriction on Fat Intake: A Systematic Review and Meta-analysis.Ann Intern Med. 2016 Oct 4;165(7):491-500. doi: 10.7326/M16-0361. Epub 2016 Jul 19. Ann Intern Med. 2016. PMID: 27428849 Review.
Cited by 2 articles
Red and Processed Meats and Health Risks: How Strong Is the Evidence?Diabetes Care. 2020 Feb;43(2):265-271. doi: 10.2337/dci19-0063. Diabetes Care. 2020. PMID: 31959642
Dietary Intakes Are Associated with HDL-Cholesterol in Survivors of Childhood Acute Lymphoblastic Leukaemia.Nutrients. 2019 Dec 5;11(12):2977. doi: 10.3390/nu11122977. Nutrients. 2019. PMID: 31817482 Free PMC article.